Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
0.7500
+0.0360
+5.04%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Novacyt (ALNOV)
Add to/Remove from a Portfolio
Add to Watchlist
- Volume: 1,093,529
- Bid/Ask: 0.0000 / 0.0000
- Day's Range: 0.7350 - 0.8290
Novacyt
0.7500
+0.0360
+5.04%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Financial Summary
- Income Statement
- Balance Sheet
- Cash Flow
- Ratios
- Dividends
- Earnings
EPA:ALNOV Financials
This summary provides an overview of the most significant critical numbers from each of the Novacyt financial reports, including theNovacyt income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.
Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the EPA:ALNOV financials over time via breakdowns of their annual reports.
Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the EPA:ALNOV financials over time via breakdowns of their annual reports.
Novacyt S.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was GBP 3.34 million compared to GBP 16.51 million a year ago. Net loss was GBP 8.35 million compared to GBP 8.7 million a year ago. Basic loss per share from continuing operations was GBP 0.12 compared to GBP 0.07 a year ago. Diluted loss per share from continuing operations was GBP 0.12 compared to GBP 0.07 a year ago. Basic loss per share was GBP 0.12 compared to GBP 0.12 a year ago. Diluted loss per share was GBP 0.12 compared to GBP 0.12 a year ago.
Advanced Financial Summary 
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter
ALNOV Income Statement & Profits
Gross margin TTM 38.51%
Operating margin TTM -178.21%
Net Profit margin TTM -322.44%
Return on Investment TTM -10.43%
Total Revenue Net Income
| Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|
| Total Revenue | 1.67 | 1.67 | 2.27 | 2.27 |
| Gross Profit | 0.832 | 0.832 | 0.683 | 0.683 |
| Operating Income | -3.27 | -3.27 | -3.74 | -3.74 |
| Net Income | -4.17 | -4.17 | -8.52 | -8.52 |
ALNOV Balance Sheet
Quick Ratio MRQ 4.53
Current Ratio MRQ 5.09
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 0.36%
Total Assets Total Liabilities
| Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|
| Total Assets | 132.15 | 132.15 | 140.9 | 140.9 |
| Total Liabilities | 24.84 | 24.84 | 25.68 | 25.68 |
| Total Equity | 107.31 | 107.31 | 115.22 | 115.22 |
%ENGLISH_NAME% Latest Cash Flow Statement
Cash Flow/Share TTM -0.25
Revenue/Share TTM 0.11
Operating Cash Flow -12.10%
Cash Net Change in Cash
| Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|
| Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
| Cash From Operating Activities | -2.85 | -2.85 | -6.03 | -6.03 |
| Cash From Investing Activities | 0.505 | 0.505 | -0.128 | -0.128 |
| Cash From Financing Activities | -0.267 | -0.267 | -0.178 | -0.178 |
| Net Change in Cash | -2.62 | -2.62 | -6.33 | -6.33 |
* In Millions of GBP (except for per share items)
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Write your thoughts about Novacyt
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
El Rey katambo Malamba
Feb 16, 2022 3:37
i need help, how do I begin buying share
0
2
Harry Carson
Feb 16, 2022 3:37
Open an account with a Stockbroker.This is easily done online .Read reviews of best online brokers How much are their fees, commission.Do they offer an advisory service?Join a free bulletin board such as advfn or lse and ask politely for advice on brokers.That's all.
1
1
murat balta
Feb 16, 2022 3:37
If you have money to burn it than you will find the way.
1
1
Harry Carson
Feb 15, 2022 17:35
Takeover?
1
0
murat balta
Jan 27, 2022 10:33
It does’nt matter what other countries policies are about covid-omicron, as long as it is active un USA it means it is it is problem for rest if the world, as everyting USA dictates not England or other any other country.
2
1
Roy Martinez
Jan 22, 2022 16:00
Volume of testing will fall as Omicron fades and travel testing is reduced.Will Novacyt fall in tandem; some experts saying Strong Buy?
1
3
Daniel Gallagher
Dec 20, 2021 13:46
Great call jonny, as always
4
3
Jonny Tr
Dec 20, 2021 13:46
haha lets see by June, i made the call on 16th Dec, it closed 367. If im wrong, im wrong & admit it. N hopefully learn something
1
0
Jonny Tr
Dec 16, 2021 12:41
head and shoulders. looks like it will fall to 150p
2
6
Ian Cotter
Dec 16, 2021 12:41
maybe when COVID goes away, until then 750 easy.
0
1
Roy Martinez
Dec 07, 2021 10:46
Why is this stock bring hit so negatively. The demand for PCR tests is rocketing view the variant and international travel regulations etc.This producer of such tests should be benefitting hugely.What are we missing here after their earlier sharp falls ?
2
1
Anon Anon
Dec 07, 2021 10:46
Market always look forward rather than rear view mirror
0
0
Roy Martinez
Dec 07, 2021 10:46
Looking Forward the demand for covid tests will acceletate tremendously in view of Omicron concern globally.
0
0
Anon Anon
Dec 07, 2021 10:46
Yes, that's already priced in. The trick of investing/trading cyclical stock is to buy when pe is highest and sell when pe is lowest
0
0
Anon Anon
Nov 26, 2021 8:08
Kaching
1
0
Katya Maddison
Oct 26, 2021 9:43
Elliot wave anaysis suggests there's an opportunity for this stock to be bottoming here
0
2
Marko Cvetkovic
Oct 26, 2021 9:43
I missed that. What does that mean?
0
2
Ravi Chander
Oct 22, 2021 14:56
Dramatic climb today? does anyone know why?
1
1
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review